Supernatants from IL-2 + anti-CD16mAb + sAJ2-treated NK cells in combination with both anti-TNF-α and anti-IFN-γ when added to OSCSCs restored tumor cell growth to the levels which were obtained with untreated OSCSCs (Figure 2F). The gene discussed is IFNG; the disease is neoplasm.